Dorzolamide hydrochloride
Dorzolamide Hydrochloride is a prescription eye drop solution that helps lower pressure inside the eye, commonly used to treat glaucoma or ocular hypertension. It works by inhibiting carbonic anhydrase, reducing fluid production in the eye. Available in 5 mL or 10 mL bottles, manufactured by Leading Pharma, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dorzolamide Hydrochloride is a prescription eye drop solution that helps lower pressure inside the eye, commonly used to treat glaucoma or ocular hypertension. It works by inhibiting carbonic anhydrase, reducing fluid production in the eye. Available in 5 mL or 10 mL bottles, manufactured by Leading Pharma, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dorzolamide hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dorzolamide hydrochloride — ANDA 215660 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215660"
}
]
|
| identifier | ANDA215660 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dorzolamide hydrochloride |
